The product features a triple action formula that includes esafoxolaner – the newly developed form of afoxolaner - combined with eprinomectin and praziquantel. This innovative broad spectrum topical ...

Internal and external parasite threats have expanded beyond their traditional regions and seasons. Many tick species, for example, are now found in places that they didn't exist a decade ago, and they ...

Animal health company Zoetis Inc. (NYSE:ZTS) traded higher Friday as analysts commented on the FDA approval of German drugmaker Boehringer Ingelheim's parasiticide NexGard Plus for dogs. The treatment ...

Boehringer Ingelheim's NexGard & NexGard Spectra gets approval to treat cutaneous diseases demodicosis and sarcoptic mange in EU & Australia: Ingelheim, Germany Friday, November 3 ...